Johanna Friedl-Naderer, Chief Commercial Officer: Dyne Therapeutics DYN Sell · Filed 06/17

Trade details

Type: Insider sale
Amount: $2,657.85
Shares · price: 145 sh · $18.33 a share
Held after: 154,208 sh
Stock: Dyne Therapeutics DYN
Person: Johanna Friedl-NadererChief Commercial Officer
Trade date: 26/06/16
Filed: 26/06/17
Days to filing: 1 days

Sold 0.1% of holdings

Share of holding sold: 0.1%

Dyne Therapeutics trades, last 26 weeks

What else happened in Dyne Therapeutics around then

Filed or reported within 30 days of the trade day · 05/17~07/16

Johanna Friedl-Naderer's recent trades

Johanna Friedl-NadererChief Commercial Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$4,186
228 sh
$4,186
Filed 05/14
Traded 05/13
Johanna Friedl-NadererChief Commercial Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$2,205
148 sh
$2,205
Filed 03/06
Traded 03/05
Johanna Friedl-NadererChief Commercial Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$2,984
144 sh
$2,984
Filed 25/12/05
Traded 25/12/05
Johanna Friedl-NadererChief Commercial Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$11.9K
894 sh
$11.9K
Filed 25/09/08
Traded 25/09/04
Johanna Friedl-NadererChief Commercial Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$1,931
144 sh
$1,931
Filed 25/09/08
Traded 25/09/05

Johanna Friedl-Naderer, Chief Officer — sold $2,658 of Dyne Therapeutics DYN · 0.1% of holdings · 10b5-1 plan | Whalegun